Loading…
Chemomab Therapeutics Ltd. is projected to rise to $2.22 by 2027, a +27% move from its current price of $1.74. CMMB is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $1.64 | $1.74 | $1.85 | +0.19% |
| Jul 14 | $1.60 | $1.75 | $1.91 | +0.37% |
| Jul 15 | $1.57 | $1.75 | $1.95 | +0.56% |
| Jul 16 | $1.55 | $1.75 | $1.98 | +0.74% |
| Jul 17 | $1.53 | $1.76 | $2.02 | +0.93% |
| Jul 18 | $1.51 | $1.76 | $2.05 | +1.12% |
| Jul 19 | $1.50 | $1.76 | $2.08 | +1.30% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.50 | $1.76 | $2.08 | +1.30% |
| Week 2 | $1.42 | $1.79 | $2.25 | +2.63% |
| Week 3 | $1.36 | $1.81 | $2.40 | +3.97% |
| Week 4 | $1.32 | $1.83 | $2.54 | +5.32% |
| Week 5 | $1.29 | $1.86 | $2.68 | +6.70% |
| Week 6 | $1.26 | $1.88 | $2.81 | +8.09% |
| Week 7 | $1.24 | $1.91 | $2.94 | +9.50% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Chemomab Therapeutics Ltd. is a clinical-stage biotechnology company focused on the discovery and development of therapeutics for fibrotic and inflammatory diseases. Its lead product candidate is nebokitug, a humanized monoclonal antibody that attenuates the basic function of CCL24 as a regulator of major inflammatory and fibrotic pathways, which has completed phase 2 clinical trial for treating primary sclerosing cholangitis, as well as in phase 2 clinical trial to treat systemic sclerosis.
The company was founded in 2011 and is based in Tel Aviv-Yafo, Israel.
Chemomab Therapeutics Ltd. trades at $1.83 per share with a market capitalization of $13.41M, ranking 5052. The current price sits within a broader forecast path that spans multiple years, with the following year-by-year average prices: 2026 $1.83, 2027 $2.32, 2028 $2.36, 2029 $2.61, 2030 $2.13, 2031 $2.69, 2032 $3.94, 2033 $3.91, 2034 $4.27, 2035 $3.75, 2040 $6.48, 2050 $13.56.
The forecast also shows the corresponding return on investment (ROI) by year, including 2030 ROI 16.3%, 2040 ROI 254.2%, and 2050 ROI 641.2%, with sentiment evolving to bullish in later years.
A major floor 57.9% below — a decisive break under it would weaken the trend.
The nearest floor, 13.8% below — buyers have tended to step in here.
The nearest ceiling, 59.2% above — a clean break opens room to run.
A major ceiling 88.1% above — clearing it would confirm fresh momentum.
Key CMMB support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CMMB market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.14 | Sell | $1.95 | Sell |
| MA 10 | $1.95 | Sell | $1.94 | Sell |
| MA 20 | $1.77 | Sell | $1.86 | Sell |
| MA 50 | $1.76 | Sell | $1.78 | Sell |
| MA 100 | $1.73 | Buy | $1.83 | Sell |
| MA 200 | $2.04 | Sell | $2.25 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 47.82 | Neutral |
| Stoch RSI (14) | 20.77 | Neutral |
| CCI (20) | -6.93 | Neutral |
| Williams %R (14) | -81.10 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | 16.00 | Buy |
| Bollinger %B (20,2) | 0.48 | Neutral |
| Stochastic %K (14) | 18.90 | Buy |
| TRIX (15) | 0.44 | Buy |
| Awesome (5,34) | 0.34 | Buy |
| Ultimate (7,14,28) | 52.36 | Neutral |
| Momentum (10) | 0.18 | Buy |
| Aroon Osc (25) | 36.00 | Buy |
| Hull MA (9) | 2.04 | Sell |
| ADX (14) | 17.34 | Neutral |
| ATR (14) | 0.15 | Info |
The 30-day technical picture is Neutral, with RSI14 at 50. SMA50 sits at $1.75 and SMA200 at $2.05, indicating near-term momentum around the current price. Support is indicated at $1.50 and resistance at $2.77, and the 30-day range spans from $1.21 to $2.77.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.44 | $1.74 | $2.99 | 0% | Neutral | |
| $1.61 | $2.22 | $3.31 | +27% | Bullish | |
| $1.52 | $2.22 | $3.53 | +28% | Bullish | |
| $1.59 | $2.46 | $4.10 | +41% | Bullish | |
| $1.22 | $1.97 | $3.42 | +13% | Neutral | |
| $1.42 | $2.40 | $4.32 | +38% | Bullish | |
| $2.01 | $3.54 | $6.56 | +103% | Bullish | |
| $1.93 | $3.54 | $6.73 | +103% | Bullish | |
| $2.01 | $3.85 | $7.51 | +121% | Bullish | |
| $1.70 | $3.38 | $6.76 | +94% | Bullish | |
| $2.55 | $5.67 | $12.45 | +226% | Bullish | |
| $5.22 | $11.60 | $26.68 | +567% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.44 | $1.74 | $2.29 | +0.00% |
| August 2026 | $1.70 | $2.06 | $2.59 | +18.22% |
| September 2026 | $1.68 | $2.06 | $2.65 | +0.15% |
| October 2026 | $1.68 | $2.09 | $2.74 | +1.60% |
| November 2026 | $1.78 | $2.23 | $2.97 | +6.62% |
| December 2026 | $1.75 | $2.22 | $2.99 | -0.44% |
Click any year to see its month-by-month CMMB forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect CMMB to range from $1.44 to $2.99 through 2026. The $1.74 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The CMMB price prediction for 2027 points to an average of $2.22 (low $1.61, high $3.31) — a potential gain of +27% on today's $1.74. Buyers look set to stay in control over this stretch.
In 2028, CMMB is projected to trade between $1.52 and $3.53, averaging $2.22 — a potential gain of +28% from today's $1.74. That is up 0% on the projected 2027 average. Momentum favours further upside here.
Chemomab Therapeutics Ltd.'s 2029 outlook centres on $2.46, within a $1.59 to $4.10 range. That is up +10% on the projected 2028 average. That marks a +41% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, CMMB could reach as high as $3.42, with a base case around $1.97 and support toward $1.22 — roughly +13% from $1.74. Price action looks broadly range-bound.
Expect CMMB to range from $1.42 to $4.32 through 2031. The $2.40 average target implies a +38% move from current prices. That is up +22% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The CMMB price prediction for 2032 points to an average of $3.54 (low $2.01, high $6.56) — a potential gain of +103% on today's $1.74. Momentum favours further upside here.
In 2033, CMMB is projected to trade between $1.93 and $6.73, averaging $3.54 — a potential gain of +103% from today's $1.74. That is 0% versus the projected 2032 average. Buyers look set to stay in control over this stretch.
Chemomab Therapeutics Ltd.'s 2034 outlook centres on $3.85, within a $2.01 to $7.51 range. That is up +9% on the projected 2033 average. That marks a +121% change versus current levels. Momentum favours further upside here.
By 2035, CMMB could reach as high as $6.76, with a base case around $3.38 and support toward $1.70 — roughly +94% from $1.74. Buyers look set to stay in control over this stretch.
Expect CMMB to range from $2.55 to $12.45 through 2040. The $5.67 average target implies a +226% move from current prices. That is up +68% on the projected 2035 average. Momentum favours further upside here.
The CMMB price prediction for 2050 points to an average of $11.60 (low $5.22, high $26.68) — a potential gain of +567% on today's $1.74. Buyers look set to stay in control over this stretch.
Investing $1,000 in CMMB today (≈ 574.712644 CMMB) could be worth
$6,666.01
+$5,666.01 (+567%) by 2050 · US Dollar
Based on the average projected CMMB price of $11.6 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CMMBwould be worth at today's price.
$1,000 invested in CMMB on Jul 10, 2025 (≈ 215.517248 CMMB) would be worth
$375
-$625 (-62.5%) today · 0.38× · US Dollar
Based on a CMMB entry price of $4.64 vs. today's $1.74.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.27 | $766.52 | -23.3% |
| 1 month ago | $1.75 | $994.29 | -0.6% |
| 3 months ago | $1.67 | $1,041.92 | +4.2% |
| 6 months ago | $1.83 | $950.82 | -4.9% |
| 1 year ago | $4.64 | $375 | -62.5% |
| All time (5.0y) ago | $69.72 | $24.96 | -97.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CMMB forecast.
Our base-case forecast reaches $3.50 around 2032.
Implied market cap at $3.50: $25.65M
The multi-year forecast shows meaningful upside beyond the current level. In 2030 the average price is projected at $2.13 with a ROI of 16.3% and a Neutral sentiment. By 2040, the average price is $6.48 with a ROI of 254.2% and a bullish sentiment.
In 2050, the average price is $13.56 with a ROI of 641.2% and a bullish sentiment. These figures suggest a path of gradual gains into the late 2020s, followed by substantial upside into the 2040s and beyond, though they are estimates and not guaranteed. The forecast highlights potential upside in later years while acknowledging inherent uncertainty.
Tap a question to reveal the answer.
In 2030 the average forecast price is $2.13 with a min of $1.32 and a max of $3.69, and a ROI of 16.3%; sentiment is Neutral.
The forecast shows a path of rising averages from $1.83 in 2026 to $13.56 by 2050, with bullish sentiment in 2027–2029 and again in 2031 onward. Notable upside is indicated by 2040 (avg $6.48, ROI 254.2%) and 2050 (avg $13.56, ROI 641.2%), but these are estimates and not guaranteed.
Yes. The 2040 max forecast is $14.23 and the 2050 max forecast is $31.20, so reaching $10 is within the forecast by 2040 and certainly by 2050.
Current price is $1.83 and market capitalization is $13.41M.
The 30-day picture is Neutral with RSI 14 at 50. The SMA50 is $1.75 and the SMA200 is $2.05. Key levels: support at $1.50 and resistance at $2.77, with a 30-day range from $1.21 to $2.77.
Chemomab Therapeutics Ltd. Community Discussion
0Share your Chemomab Therapeutics Ltd. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.